Diana Ernst, RPh, Author at Hematology Advisor

Diana Ernst, RPh

All articles by Diana Ernst, RPh

First-in-Class Treatment Approved for Hairy Cell Leukemia

The approval of Lumoxiti was based on data from a Phase 3 single-arm, open-label trial conducted in patients with histologically confirmed HCL or HCL variant with a need for therapy based on presence of cytopenias or splenomegaly and who had received prior treatment with at least 2 systemic therapies, including a purine nucleoside analog (N=80).

Next post in Lymphoma